KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Long-Term Debt Issuances (2022)

Historic Long-Term Debt Issuances for Travere Therapeutics (TVTX) over the last 5 years, with Q1 2022 value amounting to $316.2 million.

  • Travere Therapeutics' Long-Term Debt Issuances changed N/A to $316.2 million in Q1 2022 from the same period last year, while for Dec 2022 it was $316.2 million, marking a year-over-year change of. This contributed to the annual value of $316.2 million for FY2022, which is N/A changed from last year.
  • Per Travere Therapeutics' latest filing, its Long-Term Debt Issuances stood at $316.2 million for Q1 2022.
  • Travere Therapeutics' 5-year Long-Term Debt Issuances high stood at $316.2 million for Q1 2022, and its period low was $316.2 million during Q1 2022.